ORTEXORTEX News
Tracking NRG? Get live short interest, options flow, and signals on ORTEX.Sign up free →
NR
Trader NoteNRG

NRG Energy Falls 8.7% While Peers Hold Flat

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 21 Oct 2026, 19:16

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

NRG Energy has dropped 8.7% over the past week to $97.84, a sharp divergence from the near-flat performance of most utility peers, while Morgan Stanley trimmed its price target for the second time in two months.

Short sellers hold about 3.2% of the free float, a level that by itself is not extreme. What is more notable is the direction: short interest has climbed roughly 5.3% over the past month, adding around 435,000 shares between late September and mid-October before edging back fractionally this week. The borrow market is anything but tight. Availability is near its ceiling, with more than 128 million shares still available to lend, making it straightforward for new shorts to establish positions. Cost to borrow fell sharply on Tuesday to 1.30%, down from a recent peak above 2.20% earlier in the week, though that 1.30% rate is itself more than three times where it was at the start of October, suggesting borrow demand picked up meaningfully through the month even as it is now easing. Options traders are not especially defensive: the put/call ratio at 0.50 is modestly below its 20-day average of 0.55, a slight tilt toward calls rather than puts despite the price decline.

The Street's direction of travel has been uniformly downward on price targets. Morgan Stanley's Stephen Byrd lowered his target again today, from $159 to $144, while holding an Equal-Weight rating, the third consecutive cut from that desk since August. Earlier reductions came from Scotiabank, Evercore ISI and UBS following the August earnings print. The mean consensus target across the analyst panel now stands at $179, which implies considerable implied upside from the current price, but that aggregate is being pulled up by several targets set before the August selloff that may not yet reflect the current run rate. Factor scores show genuine tension between the company's track record and its recent momentum: EPS surprise ranks in the 84th percentile, meaning the company has a strong history of beating estimates, while EPS momentum over the past 30 and 90 days ranks in the bottom quarter of the universe, at the 12th and 22nd percentile respectively. The ORTEX short score of 32 places NRG in the lower half of its range, consistent with a name where positioning is building but not yet at an extreme.

Closest peer CEG fell 12.5% on the week, a steeper drop than NRG, suggesting the selloff has a sector component as well as a company-specific one. ETR and AEP, by contrast, closed the week roughly flat to slightly higher, highlighting that not all utilities are trading together.

The next earnings release is scheduled for 4 November. NRG's last two quarterly prints each produced double-digit negative reactions: the stock fell 12.8% on the day following the August 2026 report and 9.9% on the day following the May 2026 report. Both moves extended over the subsequent week, with five-day losses of 13.5% and 16.7% respectively. With the stock already down 8.7% over the past week, how the market responds to the next print, and whether Morgan Stanley's continued target reductions prove to be ahead of or behind consensus, are the data points to watch over the next fortnight.

Stocks in this article

See the live data behind this article on ORTEX.

Open NRG on ORTEX →

How this article was generated

Generated
21 Oct 2026, 19:26
Data as of
21 Oct 2026, 19:16
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.